Results 201 to 210 of about 45,441 (213)

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

New England Journal of Medicine, 2013
Simon A Rule, Peter Martin, Andre H Goy
exaly  

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

New England Journal of Medicine, 2017
Catherine Thieblemont, Lucie Oberic, Gandhi Damaj   +2 more
exaly  

Mantle Cell Lymphoma

1996
G. Ott, M. M. Ott, J. Kalla, A. Helbing, B. Schryen, T. Katzenberger, J. Bartek, A. Dürr, J. G. Müller, H. Kreipe, H. K. Müller-Hermelink   +10 more
openaire   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

New England Journal of Medicine, 2018
Constantine S Tam, Mary Ann Anderson, Rishu Agarwal   +2 more
exaly  

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Lancet, The, 2013
Dieter Hoelzer
exaly  

2016 US lymphoid malignancy statistics by World Health Organization subtypes

Ca-A Cancer Journal for Clinicians, 2016
Lauren R Teras, Carol E Desantis, James R Cerhan   +2 more
exaly  

Mantle Cell Lymphoma

2021
openaire   +1 more source

Mantle Cell Lymphoma

ASH Image Bank, 2003
openaire   +1 more source

Mantle Cell Lymphoma

2006
Georg Lenz, Martin Dreyling, Wolfgang Hiddemann   +2 more
openaire   +1 more source